Genenta Science

Milano, Italy

Genenta Science is a biotechnology company that develops gene transfer therapy for the treatment of cancer tumors.

$15.0M raised

Oct 2025

Post-IPO Equity

Biotechnology Clinical Trials Genetics Health Care

Top Investors

Mediobanca Club degli Investitori Growth Engine ENEA Tech e Biomedical iStarter

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Genenta Science

How much funding has Genenta Science raised?

Genenta Science has raised $15.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2025.

Who are Genenta Science's investors?

Genenta Science's investors include Mediobanca, Club degli Investitori, Growth Engine, ENEA Tech e Biomedical, iStarter.

Where is Genenta Science headquartered?

Genenta Science is headquartered in Milano, Italy.

What does Genenta Science do?

Genenta Science is a biotechnology company that develops gene transfer therapy for the treatment of cancer tumors.

What stage is Genenta Science at?

Genenta Science is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 26, 2025.

MLA

"Genenta Science — Funding & Investors." VCBacked, October 26, 2025, https://www.vcbacked.co/company/genenta-science. Accessed July 2, 2026.

APA

VCBacked. (2025). Genenta Science — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/genenta-science

Wikipedia (cite web)

{{cite web |title=Genenta Science — Funding & Investors |url=https://www.vcbacked.co/company/genenta-science |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 26, 2025.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K